ClinicalTrials.Veeva

Menu
N

Neuroscience Research Institute | West Palm Beach, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BHV-7000
ACP-204
Aticaprant
KarXT
GATE-251
Centanafadine
Esketamine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder (GATE-251)

The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel....

Enrolling
Major Depressive Disorder
Drug: Zelquistinel

To evaluate long-term safety exposure

Active, not recruiting
Attention Deficit/Hyperactivity Disorder
Drug: Centanafadine Hydrochloride
Locations recently updated

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...

Enrolling
Alzheimer's Disease Psychosis
Drug: Placebo
Drug: ACP-204

Trial sponsors

Biohaven logo
Janssen (J&J Innovative Medicine) logo
Acadia Pharmaceuticals logo
Karuna Therapeutics logo
Otsuka logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems